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ABSTRACT 
Nearly 30% of intensive care unit (ICU) survivors have depressive symptoms 2-12 months after 
hospital discharge. We examined the prevalence of depressive symptoms in 204 patients at 
their initial evaluation in the Critical Care Recovery Center (CCRC), an ICU survivor clinic based 
at Eskenazi Hospital in Indianapolis, IN, and risk factors for depressive symptoms. 32% (N = 65) 
had depressive symptoms on initial CCRC visit. For patients not on an antidepressant at their 
initial CCRC visit (N = 135), younger age and lower education level were associated with a 
higher likelihood of having depressive symptoms. For patients on an antidepressant at their 
initial CCRC visit (N = 69), younger age and African American race were associated with a 
higher likelihood of having depressive symptoms. Future studies will need to confirm these 
findings and examine new approaches to increase access to depression treatment and test new 
antidepressant regimens for post-ICU depression. 
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INTRODUCTION 
As the number of intensive care unit (ICU) survivors have steadily increased over the past few 
decades, there is growing awareness of the long-term physical, cognitive, and psychological 
impairments after ICU hospitalization, collectively known as post-intensive care syndrome 
(PICS).1 Systematic reviews based mostly on research studies suggest that the prevalence of 
depressive symptoms 2-12 months after ICU discharge is nearly 30%.2-5 Due to the scarcity of 
established models of care for ICU survivors, there is limited characterization of depressive 
symptoms and antidepressant regimens in this clinical population. The CCRC at Eskenazi 
Hospital is one of the first ICU survivor clinics in the US and targets a racially diverse, 
underserved population in the Indianapolis metropolitan area.6 In this study, we examined 
whether patients had depressive symptoms at their initial CCRC visit, and whether the risk 




Referral criteria to the CCRC were 18 years or older, admitted to the Eskenazi ICU, were on 
mechanical ventilation or delirious for ≥48 hours (major risk factors for the development of 
PICS), and recommended for follow-up by a critical care physician. Exclusion criterion included 
enrollment in hospice or palliative care services. IRB approval was obtained to conduct 
retrospective analyses of de-identified clinical data. Medical history and medication lists were 
collected from patients, informal caregivers, and electronic medical records. 
 
Two hundred thirty-three patients were seen in the CCRC from July 2011 to August 2016. Two 
hundred and four patients rated symptoms of depression with either the Patient Health 
Questionnaire (PHQ-9) (N = 99) or Geriatric Depression Scale (GDS)-30 (N = 105) at their initial 
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visit at the CCRC prior to receiving any treatment at the CCRC. Twenty-nine patients who did 
not complete depression questionnaires were excluded from the analyses. Patients with PHQ-9 
score ≥ 10 or GDS score ≥ 20 were categorized as having moderate to severe depressive 
symptoms.7,8 
 
Electronic medical records were reviewed to determine whether patients were on an 
antidepressant at hospital admission, hospital discharge, and the initial CCRC visit prior to any 
treatment in the CCRC. Patients who were on a tricyclic antidepressant, selective serotonin 
reuptake inhibitor, selective serotonin-norepinephrine reuptake inhibitor, noradrenergic and 
specific serotonergic antidepressant (e.g. mirtazapine), or norepinephrine and dopaminergic 
reuptake inhibitor (e.g. bupropion) at any dose were designated as being on an antidepressant. 
Prescribers of antidepressants included primary care providers, clinical providers during their 
hospital stay, and various outpatient subspecialists other than those in the CCRC. 
 
We then examined whether the risk factors for depressive symptoms differed if patients were on 
an antidepressant at their initial CCRC visit. We compared demographic and clinical 
characteristics between depressed and non-depressed patients not on an antidepressant. We 
repeated this analyses for those on an antidepressant. Dichotomous outcomes were compared 
using chi-square testing, and two-way t-tests for continuous outcomes. Demographic and 
clinical variables with P < 0.1 were included as covariates in a logistic regression model for 
depressive symptoms separately for those not an antidepressant and those on an 
antidepressant. History of depression was not included as a covariate because it is highly 
collinear with post-ICU depression.  
 
RESULTS 
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Two hundred and four ICU survivors in this study reflected a racially diverse and underserved 
population (monthly income 745.3 ± 931.5). Although most had respiratory failure and/or 
delirium during their hospital stay, 94.1% (N = 160) mostly lived independently after discharge. 
Nearly one third of patients (N = 69) were on at least one antidepressant at their initial CCRC 
visit. Out of these 69 patients, 60.9% (N = 42) had an antidepressant prescription on hospital 
admission, and 60.9% (N = 42) had an antidepressant prescription on hospital discharge. 
 
We first compared the demographic and clinical characteristics for patients with and without 
depressive symptoms at their initial CCRC visit. Patients with depressive symptoms were 
younger, less likely to have cardiac disease, more likely to have a history of depression, more 
likely to have been prescribed an antidepressant on hospital admission, more likely to be 
prescribed an antidepressant hospital discharge, and more likely to be on an antidepressant at 
their initial CCRC visit (Table 1).  
 
We then compared whether demographic and clinical characteristics for patients with and 
without depressive symptoms differed by antidepressant status at their initial CCRC visit. 
Patients with depressive symptoms not on antidepressants (N = 135) were younger, have fewer 
years of education, more likely to have a history of depression, less likely to have a cardiac 
history, and less likely to have hypertension (Supplementary Table 1). Multivariate logistic 
regression showed that only younger age (odds ratio (OR) = 0.96 per year, P = 0.023) and 
lower education (OR = 0.81, P = 0.014) remained significantly associated with depressive 
symptoms (Table 2). 
 
Patients with depressive symptoms on an antidepressant (N = 65) were younger and more likely 
to be African American (borderline significance) (Supplementary Table 2). Multivariate logistic 
regression showed that both younger age (OR = 0.92 per year, P = 0.003) and African 
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American race (OR = 4.3, P = 0.024) remained significantly associated with depressive 
symptoms (Table 2). 
CONCLUSION/DISCUSSION 
Our study demonstrated that about one-third of our ICU survivor clinical cohort had untreated or 
inadequately treated depressive symptoms at their CCRC initial visit. Many patients with 
depressive symptoms had a history of depression and/or antidepressant prescription on hospital 
admission. This suggests pre-ICU depression is a major contributor of post-ICU depression. 
These findings are consistent with the results of a large retrospective analysis of Danish ICU 
survivors which found patients were more likely to have premorbid psychiatric diagnoses 
compared to the general population.9 Another ICU survivor research study which excluded 
patients who were antidepressants prior to ICU hospitalization found that 49% of these patients 
were on an antidepressant after their ICU stay.10 Our much lower rate of patients on an 
antidepressant after their ICU stay may reflect the differences between patient populations, 
differences in healthcare systems, and differences in clinician prescribing practices. 
Younger age was associated with a higher likelihood of depressive symptoms independent of 
antidepressant status. Findings about the relationship between age and post-ICU depression 
have varied. The BRAIN-ICU group found that older age was associated with more depressive 
symptoms at 12 months post-discharge.11 On the other hand, a systematic review of post-ICU 
depression did not find any relationship between age and post-ICU depression.2,3 These 
differences may be due in part to demographic variations in cohorts. 
Our logistic regression models suggest there may also be different risk factors in patients who 
had untreated versus inadequately treated depressive symptoms. Patients who were not on an 
antidepressant at their initial CCRC visit were more likely to have a lower level of education. 
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This is consistent with the Medical Expenditure Panel Surveys study, which showed that adults 
with less than a high school education were less likely to receive depression treatment.12 In 
patients who were on antidepressants at their initial CCRC visit, African-Americans were more 
likely to have depressive symptoms. Possible reasons may include differences in receiving 
guideline-concordant antidepressant medication treatment, access to mental health 
subspecialty services, higher prevalence of treatment refractory depression, and differences in 
responses to antidepressant treatments.13,14  
 
Strengths of our study include detailed characterization for a fairly large ICU survivor clinic 
population and a racially diverse cohort. To the best of our knowledge, our study is also the first 
to examine whether there may be different risk factors for depressive symptoms based on 
antidepressant status. Limitations include the lack of information about nonpharmacologic 
antidepressant treatment and the inability to assess whether noncompliance, insufficient dose, 
or insufficient time on antidepressants contributed to inadequate antidepressant treatment. 
Antidepressants may have also been prescribed for other purposes such as smoking cessation, 
neuropathic pain and migraine headaches. However, since 72.4% patients on antidepressants 
had a history of depression, it is likely that most of them were on antidepressants to treat 
depression. 
 
Other limitations include potential biases in our clinical cohort. Over the last five years, the 
CCRC has provided care to over 200 ICU survivors. With 1100 mechanically ventilated 
admissions per year, only 1.8% of survivors are seen. The referral criteria for the CCRC is a 
major source of selection bias which likely over-represents PICS. Since patients are seen in the 
CCRC about three months after hospital discharge, there is also informant censoring due to 
death. Physically sicker survivors in nursing home facilities were less likely to be included. 
Finally, the small cohort size may have resulted in an underpowered study. 
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Future studies will need to confirm our findings about the high prevalence of post-ICU 
depression and different responses to antidepressant medications by certain groups. Pre-ICU 
depression, lack of antidepressant treatment, and inadequate antidepressant treatment are 
major causes of post-ICU depression. Currently the CCRC offers pharmacotherapy, problem 
solving therapy, or referral to mental health specialists to treat patients with depressive 
symptoms. ICU survivor clinics, such as the CCRC, may become important settings to increase 
access to depression treatment for those at higher risk for post-ICU depression as well to test 
new antidepressant regimens for those with inadequately treated depression. 
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